232 related articles for article (PubMed ID: 31447124)
1. The surgical outcome and recurrence rate of tenosynovial giant cell tumor in the elbow: a literature review.
Al Farii H; Zhou S; Turcotte R
J Shoulder Elbow Surg; 2019 Sep; 28(9):1835-1840. PubMed ID: 31447124
[TBL] [Abstract][Full Text] [Related]
2. Surgical outcomes of patients with diffuse-type tenosynovial giant-cell tumours: an international, retrospective, cohort study.
Mastboom MJL; Palmerini E; Verspoor FGM; Rueten-Budde AJ; Stacchiotti S; Staals EL; Schaap GR; Jutte PC; Aston W; Gelderblom H; Leithner A; Dammerer D; Takeuchi A; Thio Q; Niu X; Wunder JS; ; van de Sande MAJ
Lancet Oncol; 2019 Jun; 20(6):877-886. PubMed ID: 31029509
[TBL] [Abstract][Full Text] [Related]
3. Giant cell tumor of tendon sheath: Open surgery or arthroscopic synovectomy? A systematic review of the literature.
Noailles T; Brulefert K; Briand S; Longis PM; Andrieu K; Chalopin A; Gouin F
Orthop Traumatol Surg Res; 2017 Sep; 103(5):809-814. PubMed ID: 28428036
[TBL] [Abstract][Full Text] [Related]
4. Tenosynovial giant cell tumor in the foot and ankle.
Çevik HB; Kayahan S; Eceviz E; Gümüştaş SA
Foot Ankle Surg; 2020 Aug; 26(6):712-716. PubMed ID: 31526689
[TBL] [Abstract][Full Text] [Related]
5. Optimal Treatment for Tenosynovial Giant Cell Tumor of the Hand.
Kitagawa Y; Takai S
J Nippon Med Sch; 2020 Sep; 87(4):184-190. PubMed ID: 32350187
[TBL] [Abstract][Full Text] [Related]
6. Tenosynovial giant cell tumor-diffuse type, treated with a novel colony-stimulating factor inhibitor, pexidartinib: initial experience with MRI findings in three patients.
Helming A; Hansford B; Beckett B
Skeletal Radiol; 2022 May; 51(5):1085-1091. PubMed ID: 34586485
[TBL] [Abstract][Full Text] [Related]
7. Monoarticular, Multifocal, Localized Tenosynovial Giant Cell Tumor of the Knee: A Case Report.
Tedesco AJ; Tedesco NS
JBJS Case Connect; 2020; 10(1):e0479. PubMed ID: 32044773
[TBL] [Abstract][Full Text] [Related]
8. Tenosynovial Giant Cell Tumor in the Hand: Experience with 173 Cases.
Çevik HB; Kayahan S; Eceviz E; Gümüştaş SA
J Hand Surg Asian Pac Vol; 2020 Jun; 25(2):158-163. PubMed ID: 32312203
[No Abstract] [Full Text] [Related]
9. Medium-term Outcomes of Excision Using Surgical Microscope of Tenosynovial Giant Cell Tumors of the Hand.
Nakamura Y; Tada K; Akahane M; Honda S; Horie S; Ikeda K; Tsuchiya H
Anticancer Res; 2024 Jan; 44(1):375-378. PubMed ID: 38159975
[TBL] [Abstract][Full Text] [Related]
10. [Diagnosis and treatment of diffuse tenosynovial giant cell tumor arising from temporomandibular joints].
Meng JH; Guo YX; Luo HY; Guo CB; Ma XC
Beijing Da Xue Xue Bao Yi Xue Ban; 2016 Dec; 48(6):1049-1054. PubMed ID: 27987512
[TBL] [Abstract][Full Text] [Related]
11. Tenosynovial Giant Cell Tumor (TSGCT) of the hip: MRI accuracy and results of surgical treatment.
Schenk P; Schöni M; Urbanschitz L; Filli L; Rahm S; Zing P
Acta Orthop Belg; 2023 Mar; 89(1):65-69. PubMed ID: 37294987
[TBL] [Abstract][Full Text] [Related]
12. Arthroscopic Excision of a Localized Tenosynovial Giant Cell Tumor of the Knee: A Case Report.
Zmerly H; Draghetti M; Moscato M; Akkawi I
Curr Rheumatol Rev; 2024; 20(4):459-464. PubMed ID: 38231053
[TBL] [Abstract][Full Text] [Related]
13. Clinical and morphological correlations and histopathology of joint damage in patients with diffuse-type tenosynovial giant cell tumor.
Dyadyk OO; Hryhorovska AV
Wiad Lek; 2019; 72(12 cz 1):2269-2276. PubMed ID: 32124739
[TBL] [Abstract][Full Text] [Related]
14. Oncological and functional outcomes of modified arthroscopic resection for intra-articular tenosynovial giant cell tumor of the knee using multiple portals.
Higa K; Uehara F; Azuma C; Oshiro H; Tome Y; Nishida K
J Orthop Surg (Hong Kong); 2023; 31(3):10225536231220413. PubMed ID: 38051283
[TBL] [Abstract][Full Text] [Related]
15. Invasion Patterns and Long-Term Clinical Outcomes of Diffuse Tenosynovial Giant Cell Tumor of the Ankle Joint.
Yotsuya K; Shido Y; Matsuyama Y
Cureus; 2024 Mar; 16(3):e56148. PubMed ID: 38487651
[TBL] [Abstract][Full Text] [Related]
16. Image-guided, intensity-modulated radiotherapy for the treatment of diffuse-type tenosynovial giant cell tumor of the knee: Case report and review of the literature.
Xiang X; Jiang W; Qiu C; Xiao N; Liang J
Medicine (Baltimore); 2021 Jul; 100(28):e26659. PubMed ID: 34260572
[TBL] [Abstract][Full Text] [Related]
17. Prediction of local recurrence in tenosynovial giant cell tumor of the knee: Based on preoperative MRI evaluation into disease subtypes and severity.
Kim JH; Lee SK; Kim JY
PLoS One; 2023; 18(6):e0287028. PubMed ID: 37315053
[TBL] [Abstract][Full Text] [Related]
18. Tenosynovial Giant-Cell Tumors of the Foot and Ankle: A Critical Analysis Review.
Fraser EJ; Sullivan M; Maclean F; Nesbitt A
JBJS Rev; 2017 Jan; 5(1):. PubMed ID: 28135228
[No Abstract] [Full Text] [Related]
19. Localized and diffuse forms of tenosynovial giant cell tumor (formerly giant cell tumor of the tendon sheath and pigmented villonodular synovitis).
Gouin F; Noailles T
Orthop Traumatol Surg Res; 2017 Feb; 103(1S):S91-S97. PubMed ID: 28057477
[TBL] [Abstract][Full Text] [Related]
20. Diffuse-Type Tenosynovial Giant Cell Tumor: What Are the Important Findings on the Initial and Follow-Up MRI?
Choi WS; Lee SK; Kim JY; Kim Y
Cancers (Basel); 2024 Jan; 16(2):. PubMed ID: 38254890
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
